Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
$4.40
+0.200 (+4.76%)
At Close: May 08, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $6.10 $80.02 Wednesday, 8th May 2024 ATXI stock ended at $4.40. This is 4.76% more than the trading day before Tuesday, 7th May 2024. During the day the stock fluctuated 13.73% from a day low at $4.15 to a day high of $4.72.
90 days $71.43 $25.28
52 weeks $0.340 $25.28

Historical Avenue Therapeutics, Inc. prices

Date Open High Low Close Volume
Feb 27, 2024 $0.143 $0.160 $0.140 $0.155 1 400 745
Feb 26, 2024 $0.139 $0.148 $0.135 $0.147 1 451 322
Feb 23, 2024 $0.143 $0.146 $0.132 $0.135 1 627 057
Feb 22, 2024 $0.145 $0.149 $0.142 $0.142 2 012 189
Feb 21, 2024 $0.152 $0.152 $0.143 $0.149 1 218 905
Feb 20, 2024 $0.141 $0.154 $0.141 $0.149 1 039 010
Feb 16, 2024 $0.143 $0.153 $0.143 $0.146 1 031 554
Feb 15, 2024 $0.153 $0.153 $0.140 $0.147 458 668
Feb 14, 2024 $0.144 $0.147 $0.141 $0.146 510 251
Feb 13, 2024 $0.160 $0.160 $0.125 $0.145 1 036 579
Feb 12, 2024 $0.147 $0.150 $0.142 $0.149 1 557 261
Feb 09, 2024 $0.137 $0.148 $0.136 $0.145 960 143
Feb 08, 2024 $0.142 $0.142 $0.132 $0.141 938 666
Feb 07, 2024 $0.120 $0.139 $0.113 $0.136 3 685 440
Feb 06, 2024 $0.140 $0.143 $0.115 $0.120 7 944 048
Feb 05, 2024 $0.144 $0.144 $0.137 $0.138 973 847
Feb 02, 2024 $0.147 $0.153 $0.138 $0.140 1 374 059
Feb 01, 2024 $0.145 $0.153 $0.140 $0.147 1 186 515
Jan 31, 2024 $0.143 $0.152 $0.143 $0.148 1 092 985
Jan 30, 2024 $0.148 $0.154 $0.141 $0.150 1 024 204
Jan 29, 2024 $0.150 $0.158 $0.143 $0.152 1 374 709
Jan 26, 2024 $0.140 $0.156 $0.140 $0.150 2 947 756
Jan 25, 2024 $0.143 $0.145 $0.137 $0.141 1 151 463
Jan 24, 2024 $0.140 $0.150 $0.131 $0.145 1 662 766
Jan 23, 2024 $0.141 $0.142 $0.135 $0.141 1 561 377
Click to get the best stock tips daily for free!

About Avenue Therapeutics, Inc.

Avenue Therapeutics. Avenue Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes products primarily for use in the acute/intensive care hospital setting. Its product candidate is intravenous Tramadol, a synthetic dual-acting opioid, which is in Phase III clinical trials for the treatment of post-operative acute pain. The company was incorporated in 2015 and is based in New York, New York.... ATXI Profile

Golden Star

Ticker Date Change Price
WMT May 06 0.718% $59.87
UNP May 06 2.80% $239.21
JPM May 06 1.90% $192.00
INGR May 03 3.40% $114.56
BNDX May 03 0.247% $48.68
BBCA May 03 0.99% $65.44
ADTH May 03 5.86% $3.24
ASH May 03 1.78% $95.85
INVH May 03 0.90% $34.39
INTU May 03 0.502% $629.27
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT